Nektar Therapeutics (NKTR)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Nektar Therapeutics (NKTR)
17 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on NKTR
- SA Editor Miriam Metzinger(8)
- Notable Calls(4)
- RJ Steffens (2)
- Mike Havrilla(1)
- Derek Lowe(1)
Most popular authors
(tracked in watchlists)
- SA Editor Judy Weil(228)
- Mike Havrilla(160)
- SA Editor Miriam Metzinger(142)
- Notable Calls(111)
- Derek Lowe(38)
Most commented on authors
- 40 Top Rated Emerging Bio-Pharma Stocks
- Pharmas and Biotech: Vying for Outsize Insulin Profits
- Generex Biotech's Oral-lyn Granted Special Access Authorization by Health Canada
- Generex Biotechnology: Oral-lyn Buccal Insulin Takes Center Stage
- Nektar, Mannkind Suffer from Pfizer's (Discontinued) Inhaled Insulin Effects
- Nektar: Sometimes Fundamental Analysis Takes Awhile To Work
- Nektar Tanks on Pfizer's Exubera Decision
- Cowen Sees Nektar Outperforming Market By 30%+
- Nektar Therapeutics Should Be Juiced By Pfizer Messaging Campaign
- Nektar Therapeutics: Strong Short Squeeze Candidate
- The Next Great Biotech Short Squeeze
- Lower Exubera Projections Bad News For Pfizer, Nektar
- Aradigm Focuses on Inhaled Drugs
- Rob Black's Healthcare Stock Report
-
Analyst Upgrades & Downgrades for Friday, July 21, 2006
on Jul 21, 2006
- Neurocrine's Implosion: Let The Dust Settle Before Buying (NBIX)
- Barron’s Tepid Review of Amylin Pharmaceuticals (AMLN, PFE, NKTR, SNY, NVO)
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »